Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
columbia university
depression
2
×
alpha
andela
antisense oligonucleotide
atai life sciences
benzodiazepines
biogen
biotech
blackstone group
blackstone life sciences
boston
boston blog main
boston top stories
christina sass
clinical trials
co-founder
compass pathways
david goldstein
drug discovery
drugs
ela madej
epi4k
epilepsy
essential tremor
fifty years
investing
kiran reddy
life sciences
major depressive disorder
marcio souza
medicine
mental health
miami
multidisciplinary association for psychedelic studies
national blog main
national top stories
new york blog main
new york top stories
nue life health
What
backed
2
×
aims
allow
atai
brought
cause
ceo
clinical
companies
compass
compound
depression
drugs
epilepsy
founder
genes
genetic
ipo
journey
life
links
magic
marcio
medicines
million
mushroom
mutations
neuro
new
pathways
paypal
peter
praxis
precision
prescribe
psilocybin
psychedelics
psychotherapists
rage
raised
Language
unset
Current search:
backed
×
depression
×
@techcrunch.com
2 years ago
Journey Clinical raises $3M to allow psychotherapists to prescribe psychedelics
@xconomy.com
3 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
